Allogeneic Stem Cell Transplant


Myeloablative Treatment Regimens Superior to Reduced Intensity Treatment for AML and MDS Patients Undergoing Stem Cell Transplant (December 30, 2015)

Hematopoietic Stem Cell Transplant (SCT) is a standard and potentially curative treatment for individuals with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Historically only high dose... Continue Reading

Data Back Stem Cell Transplant as Cure for Sickle Cell (December 28, 2015)

A recent report suggests that over 90% of patients with sickle cell disease treated with an HLA-matched sibling stem-cell transplant (SCT) survive, free of disease, 3 years after treatment and are probably... Continue Reading

Promising Survival for AML Patients Treated with Stem Cells from Related Half Matched Donor (July 30, 2015)

Patients with acute myeloid leukemia (AML) may have a promising new treatment option. Research shows that stem cell transplant from a “half matched” related donor plus chemotherapy results in similar... Continue Reading

Antiretroviral Drug May Prevent Graft-Versus-Host Disease (August 6, 2012)

The drug Selzentry® (maraviroc), which is typically used to treat HIV infection, may help prevent graft-versus-host disease (GVHD), a potentially lethal complication of stem cell transplants, according... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients.... Continue Reading

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported... Continue Reading

Specific Changes in Immune System Components Predict Likelihood of Fungal Infection in Allogeneic Stem Cell Transplants (October 27, 2008)

Specific Changes in Immune System Components Predict Likelihood of Fungal Infection in Allogeneic Stem Cell Transplants Changes in specific immune system components referred to as toll-like receptors (TLRs)... Continue Reading

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia (August 12, 2008)

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising;... Continue Reading

Statins May Reduce Acute Graft-versus-host Disease (June 18, 2008)

Statins May Reduce Acute Graft-versus-host Disease Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients... Continue Reading

Stem Cell Transplant Procedures Vary Throughout the World (May 9, 2008)

Stem Cell Transplant Procedures Vary Throughout the World Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood... Continue Reading

Use of Antifungal Agents Decreases Death in Allogeneic Stem Cell Transplants (December 4, 2007)

Use of Antifungal Agents Decreases Death in Allogeneic Stem Cell Transplants According to an article recently published in the Journal of Clinical Oncology, preventive use of antifungal agents improves... Continue Reading

Allogeneic Stem Cell Transplants Associated with Risk for Diabetes and Hypertension (February 7, 2007)

Allogeneic Stem Cell Transplants Associated with Risk for Diabetes and Hypertension According to an article recently published in the journal Blood, allogeneic stem cell transplants are associated with... Continue Reading

Umbilical Cord Transplants Provide Same Outcomes as Related Allogeneic Stem Cell Transplants (February 7, 2007)

Umbilical Cord Transplants Provide Same Outcomes as Related Allogeneic Stem Cell Transplants According to an article recently published in Blood, using umbilical cord blood for stem cell transplants provides... Continue Reading

Noxavil® May be Superior for Prevention of Fungal Infections in Cancer Patients (January 26, 2007)

Noxavil® May be Superior for Prevention of Fungal Infections in Cancer Patients According to two articles recently published in the New England Journal of Medicine, the anti-fungal agent Novaxil® (posaconazole)... Continue Reading

Beclomethasone May Improve Survival in Allogeneic Stem Cell Transplants (January 24, 2007)

Beclomethasone May Improve Survival in Allogeneic Stem Cell Transplants According to an early online publication in the journal Blood, the use of the anti-inflammatory agent beclomethasone may help to... Continue Reading

Specific Stem Cells Reduce Graft-versus-host-disease Among Stem Cell Transplant Recipients (December 14, 2006)

Specific Stem Cells Reduce Graft-versus-host-disease Among Stem Cell Transplant Recipients According to results presented at the 2006 annual meeting of the American Society of Hematology (ASH), mesenchymal... Continue Reading

Risk of Solid Cancers Increased for Some Patients Undergoing Allogeneic Stem Cell Transplants (November 28, 2006)

Risk of Solid Cancers Increased for Some Patients Undergoing Allogeneic Stem Cell Transplants According to an early online publication in the journal Cancer, some patients who have undergone an allogeneic... Continue Reading

Kepivance® Reduces Mucositis After Allogeneic Stem Cell Transplantation (November 2, 2006)

Kepivance® Reduces Mucositis After Allogeneic Stem Cell Transplantation According to an article recently published in the journal Blood, Kepivance® (palifermin, keritinocyte growth factor), given before... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS